Concepedia
Statistics
Publications
18
Citations
2.3K
H-Index
16
Active since
1999
Affiliations
Portola Pharmaceuticals (United States)(Current)
Millennium Engineering and Integration (United States)
University of North Carolina at Chapel Hill
Francis DeGuzman is an author at Portola Pharmaceuticals (United States) specializing in medicine, hematology, and thrombosis.
Top concepts
MedicineHematologyThrombosisPharmacologyHealthPharmacotherapyImmunologyCell BiologyAtherosclerosisVascular Biology
Publications per year
1999–2018
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach et al. · Nature Medicine · 2013 · 689 citations
Thrombosis, Venous Thrombosis, Cardiovascular Disease +13
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
Patrick André, Suzanne M. Delaney, Thomas J. LaRocca et al. · Journal of Clinical Investigation · 2003 · 347 citations · Full text
Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function
Debbie A. Law, Francis DeGuzman, Patrick W. Heiser et al. · Nature · 1999 · 317 citations
Signal Transduction, Signaling Pathway, Blood Platelet +11
A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V
Vanitha Ramakrishnan, Francis DeGuzman, Ming Bao et al. · Proceedings of the National Academy of Sciences · 2001 · 170 citations
Immunology, Protease Thrombin, Thrombosis +18
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly, Uma Sinha, Pierrette André et al. · Blood · 2010 · 131 citations · Full text
1–5 of 18